News & Views in ... Alzheimer'a[euro][TM]s Disease

Citation metadata

Date: Sept. 2011
From: Therapy(Vol. 8, Issue 5)
Publisher: Future Medicine Ltd.
Document Type: Report
Length: 503 words
Lexile Measure: 1250L

Document controls

Main content

Article Preview :

A group of researchers at Johns Hopkins University (MD, USA), have found an anticonvulsant drug to improve memory and brain function in adults with the condition amnestic mild cognitive impairment (aMCI), which often leads to Alzheimer'âs disease (AD). These results were presented at the Alzheimer'âs Association International Conference (AAIC) in Paris, France.

Amnestic mild cognitive impairment is characterized by episodic memory impairment in the absence of clinical dementia. This condition often represents a transitional stage between normal aging and AD. Researchers have proposed that excess brain activity in people with aMCI may contribute to brain dysfunction that underlies memory loss. This is contrary to the previous theory that hyperactivity observed in the aMCI brain is a compensatory mechanism for impaired ability to form new memories....

Source Citation

Source Citation   

Gale Document Number: GALE|A268609824